Vale Luís, Ribeiro Ana Margarida, Costa Daniel, Morgado Afonso, Antunes-Lopes Tiago, Dinis Paulo, Silva Carlos, Pacheco-Figueiredo Luís
Department of Urology, Centro Hospitalar Universitário São João, Porto, Portugal.
Department of Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal.
Cent European J Urol. 2020;73(1):55-61. doi: 10.5173/ceju.2020.0051. Epub 2020 Feb 25.
Metabolic abnormalities are one of the most important risk factors for urinary stone disease. Our objective was to determine the prevalence of metabolic abnormalities in patients referred to the urolithiasis outpatient clinic of a tertiary centre.
We performed a cross-sectional study evaluating 67 patients referred to the urolithiasis outpatient clinic. Metabolic evaluation was performed, including one 24-hour urine sample.
Metabolic abnormalities could be identified in 92.5% patients. Almost a quarter of the patients had only one metabolic abnormality and 67.6% had more than one abnormality. The most prevalent metabolic abnormalities were hypercalciuria (54.5%), hyperoxaluria (34.7%) and hyperuricosuria (32.3%). Patients with hypercalciuria were older (54.7 vs. 47.8 years, p = 0.018) and family history of stone disease was significantly more frequent among patients with hyperoxaluria (71.4% vs. 28.6%, p = 0.013). There was a positive linear relationship between body mass index (BMI) and urinary calcium (r = 0.247, p = 0.048) and a negative linear relationship between BMI and urinary pH (r = -0.254, p = 0.046).
Given the high prevalence of metabolic abnormalities, metabolic evaluation should be performed in every patient with urolithiasis evaluated in a tertiary setting.
代谢异常是尿路结石病最重要的危险因素之一。我们的目的是确定在一家三级中心的尿路结石门诊就诊患者中代谢异常的患病率。
我们进行了一项横断面研究,评估了67名转诊至尿路结石门诊的患者。进行了代谢评估,包括采集一份24小时尿液样本。
92.5%的患者可发现代谢异常。近四分之一的患者仅有一项代谢异常,67.6%的患者有一项以上异常。最常见的代谢异常是高钙尿症(54.5%)、高草酸尿症(34.7%)和高尿酸尿症(32.3%)。高钙尿症患者年龄较大(54.7岁对47.8岁,p = 0.018),高草酸尿症患者中结石病家族史明显更常见(71.4%对28.6%,p = 0.013)。体重指数(BMI)与尿钙之间存在正线性关系(r = 0.247,p = 0.048),BMI与尿pH之间存在负线性关系(r = -0.254,p = 0.046)。
鉴于代谢异常的高患病率,在三级医疗机构评估的每一位尿路结石患者都应进行代谢评估。